Search by Drug Name or NDC

    NDC 66215-0718-01 UPTRAVI 1800 ug/10mL Details

    UPTRAVI 1800 ug/10mL

    UPTRAVI is a INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actelion Pharmaceuticals US, Inc.. The primary component is SELEXIPAG.

    Product Information

    NDC 66215-0718
    Product ID 66215-718_f9b62ce2-37c1-2e5c-e053-6394a90a657b
    Associated GPIs 40120070002120
    GCN Sequence Number 082563
    GCN Sequence Number Description selexipag VIAL 1800 MCG INTRAVEN
    HIC3 B1C
    HIC3 Description PULMONARY ANTIHYPERTENSIVES, PROSTACYCLIN-TYPE
    GCN 50017
    HICL Sequence Number 042922
    HICL Sequence Number Description SELEXIPAG
    Brand/Generic Brand
    Proprietary Name UPTRAVI
    Proprietary Name Suffix n/a
    Non-Proprietary Name Selexipag
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 1800
    Active Ingredient Units ug/10mL
    Substance Name SELEXIPAG
    Labeler Name Actelion Pharmaceuticals US, Inc.
    Pharmaceutical Class Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA214275
    Listing Certified Through 2024-12-31

    Package

    NDC 66215-0718-01 (66215071801)

    NDC Package Code 66215-718-01
    Billing NDC 66215071801
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (66215-718-01) / 10 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2021-07-29
    NDC Exclude Flag N
    Pricing Information N/A